|EP147-C01||High-bind Plate||1 plate|
|EP147-C02||Human TNFR2||15 μg|
|EP147-C03||Biotinylated Human TNF-alpha||10 μg|
|EP147-C04||Anti-TNF-alpha Neutralizing Antibody||20 μg|
|EP147-C06||Coating Buffer||12 mL|
|EP147-C07||10xWashing Buffer||50 mL|
|EP147-C08||Blocking Buffer||50 mL|
|EP147-C09||Substrate Solution||12 mL|
|EP147-C10||Stop Solution||7 mL|
Tumor necrosis factor alpha (TNFα) is a cytokine produced primarily by monocytes and macrophages. It is found in synovial cells and macrophages in the tissues.The primary role of TNFα is in the regulation of immune cells. TNFα is able to induce apoptotic cell death, to induce inflammation, and to inhibit tumorigenesis and viral replication. Dysregulation of TNFα production has been implicated in a variety of human diseases, including major depression, Alzheimers disease and cancer. Recombinant TNFα is used as an immunostimulant under the INN tasonermin. TNFα can be produced ectopically in the setting of malignancy and parallels parathyroid hormone both in causing secondary hypercalcemia and in the cancers with which excessive production is associated.
This kit is developed for screening for inhibitors of human TNF-alpha binding to human TNFR2.
It is for research use only.
Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.
The unopened kit is stable for 12 months from the date of manufacture if stored at 2°C to 8°C.
The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
This inhibitor screening ELISA kit is designed to facilitate the identification and characterization of new TNF-alpha pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated human TNF-alpha to immobilized human TNFR2 in a functional ELISA assay, and employs a simple colorimetric ELISA platform. Briefly, we provide you with a human Biotinylated TNF-alpha protein, a human TNFR2 protein, an anti-TNF-alpha neutralizing antibody (as method verified Std.), and Streptavidin-HRP reagent.
Your experiment will include 4 simple steps:
a) Coat the plate with human TNFR2.
b) Add your molecule of interest to the tests.
c) Add human TNF-alpha-Biotin to bind the coated TNFR2.
d) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.
Finally, the half maximal inhibitory concentration (IC50) of your compound to TNF-alpha: TNFR2 binding will be determined by comparing OD readings among different experimental groups.
典型数据-Typical Data Please refer to DS document for The assay protocol.
INHIBITION OF TNF-alpha [Biotinylated]: TNFR2 BINDING BY ANTI- TNF-alpha NEUTRALIZING ANTIBODY
Serial dilutions of Anti- TNF-alpha Neutralizing antibody (Catalog # EP147-C04) (1:1 serial dilution, from 10 μg/mL to 0.02μg/mL) was added into Biotinylated TNF-alpha: TNFR2 binding reactions. The assay was performed according to the protocol described below. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).